Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury

Stroke is one of the major causes of death and disability in the United States. After cerebral ischemia and reperfusion injury, the generation of reactive oxygen species (ROS) and reactive nitrogen species may contribute to the disease process through alterations in the structure of DNA, RNA, proteins, and lipids. We generated various nanoparticles (liposomes, polybutylcyanoacrylate (PBCA), or poly(lactide-co-glycolide) (PLGA)) that contained active superoxide dismutase (SOD) enzyme (4,000 to 20,000 U/kg) in the mouse model of cerebral ischemia and reperfusion injury to determine the impact of these molecules. In addition, the nanoparticles were untagged or tagged with nonselective antibodies or antibodies directed against the N-methyl-D-aspartate (NMDA) receptor 1. The nanoparticles containing SOD protected primary neurons in vitro from oxygen-glucose deprivation (OGD) and limited the extent of apoptosis. The nanoparticles showed protection against ischemia and reperfusion injury when applied after injury with a 50% to 60% reduction in infarct volume, reduced inflammatory markers, and improved behavior in vivo. The targeted nanoparticles not only showed enhanced protection but also showed localization to the CA regions of the hippocampus. Nanoparticles alone were not effective in reducing infarct volume. These studies show that targeted nanoparticles containing protective factors may be viable candidates for the treatment of stroke.

[1]  A. Shuaib,et al.  Neuronal protection with superoxide dismutase in repetitive forebrain ischemia in gerbils. , 1994, Free radical biology & medicine.

[2]  W. Armstead,et al.  Polyethylene Glycol Superoxide Dismutase and Catalase Attenuate Increased Blood–Brain Barrier Permeability After Ischemia in Piglets , 1992, Stroke.

[3]  D. Begley.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. , 2004, Pharmacology & therapeutics.

[4]  A. Saito,et al.  Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1. , 2004, Brain research. Molecular brain research.

[5]  I. Klatzo.  Brain oedema following brain ischaemia and the influence of therapy. , 1985, British journal of anaesthesia.

[6]  Francesco M Veronese,et al.  Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. , 2002, Advanced drug delivery reviews.

[7]  I. Klatzo.  Blood-brain barrier and ischaemic brain oedema. , 1987, Zeitschrift fur Kardiologie.

[8]  V. Labhasetwar,et al.  Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  H. Kontos.  George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. , 1985, Circulation research.

[10]  R. Koehler,et al.  Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. , 1991, Stroke.

[11]  M. Kindy,et al.  Protective effects of incensole acetate on cerebral ischemic injury , 2012, Brain Research.

[12]  S. Bondy,et al.  Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes , 1990, Neurochemistry International.

[13]  P. Chan,et al.  Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. , 1990, Stroke.

[14]  I. Batinic-Haberle,et al.  Oxidants, antioxidants and the ischemic brain , 2004, Journal of Experimental Biology.

[15]  C. Allen,et al.  Oxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke , 2009, International journal of stroke : official journal of the International Stroke Society.

[16]  M. Miller,et al.  Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. , 1993, The American journal of physiology.

[17]  C. Marie,et al.  Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. , 1989, Stroke.

[18]  C. Agardh,et al.  Free radicals and brain damage. , 1989, Cerebrovascular and brain metabolism reviews.

[19]  S. Cuzzocrea,et al.  Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets. , 2008, Current medicinal chemistry.

[20]  R. M. Adibhatla,et al.  Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. , 2008, BMB reports.

[21]  S. Finklestein,et al.  Postischemic Infusion of Cu/Zn Superoxide Dismutase or SOD:Tet451 Reduces Cerebral Infarction Following Focal Ischemia/Reperfusion in Rats , 1997, Experimental Neurology.

[22]  C. Epstein,et al.  Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase gene knockout mutant mice. , 1997, Acta neurochirurgica. Supplement.

[23]  W. Mundy,et al.  Age-related changes in reactive oxygen species production in rat brain homogenates. , 2000, Neurotoxicology and teratology.

[24]  P. Narasimhan,et al.  Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. , 2011, Antioxidants & redox signaling.

[25]  M. Mattson,et al.  Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal Ischemia In Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis , 2000, The Journal of Neuroscience.

[26]  K. Pong.  Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics , 2003, Expert opinion on biological therapy.

[27]  F. Beuschlein,et al.  Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. , 2012, The Journal of endocrinology.

[28]  P. H. Chan.  Oxygen Radicals in Focal Cerebral Ischemia , 1994, Brain pathology.

[29]  Peishan Liu-Snyder,et al.  Understanding Secondary Injury , 2012, The Quarterly Review of Biology.

[30]  G. Rosenberg,et al.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.

[31]  T M Allen,et al.  In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. , 1998, Cancer research.

[32]  A. Vertegel,et al.  Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents , 2011, Biotechnology and bioengineering.

[33]  黒岩 俊彦.  The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion , 1986 .

[34]  J S Beckman,et al.  Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. , 1989, The American journal of physiology.

[35]  V. Labhasetwar,et al.  Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress , 2008, Applied biochemistry and biotechnology.

[36]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[37]  M. Spatz.  Past and recent BBB studies with particular emphasis on changes in ischemic brain edema: dedicated to the memory of Dr. Igor Klatzo. , 2010, Acta neurochirurgica. Supplement.

[38]  P. Chan.  Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  J. Guest,et al.  An Appraisal of Ongoing Experimental Procedures in Human Spinal Cord Injury , 2005, Journal of neurologic physical therapy : JNPT.

[40]  S. Moochhala,et al.  Involvement of ROS in BBB dysfunction , 2009, Free radical research.

[41]  A. Tuttolomondo,et al.  Neuron protection as a therapeutic target in acute ischemic stroke. , 2009, Current topics in medicinal chemistry.

[42]  R. Fishman,et al.  Protective effects of liposome‐entrapped superoxide dismutase on posttraumatic brain edema , 1987, Annals of neurology.

[43]  M. Kindy,et al.  Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse , 2008, Brain Research.

[44]  C. Epstein,et al.  Overexpression of SOD1 in Transgenic Rats Protects Vulnerable Neurons Against Ischemic Damage After Global Cerebral Ischemia and Reperfusion , 1998, The Journal of Neuroscience.

[45]  C. Epstein,et al.  Chapter 6 Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemia , 1993 .

[46]  J. Ellsworth,et al.  Time Window of Fibroblast Growth Factor-18—Mediated Neuroprotection after Occlusion of the Middle Cerebral Artery in Rats* , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  Nengqin Jia,et al.  Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain , 2012, Nanotechnology.

[48]  C. Epstein,et al.  Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemia. , 1993, Progress in brain research.

[49]  D. Hess,et al.  Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke , 2004, Brain Research.

[50]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.